Biorem Inc (BRM) AI Stock Analysis

• Market Cap: C$35.95M
• Dividend Yield: N/A
• Average Volume (3M): 122.52K
• Price to Earnings (P/E): 12.9
• Beta (1Y): 0.35
• Revenue Growth: 29.80%
• EPS Growth: -11.58%
• Country: CA
• Employees: 57
• Sector: Utilities
• Sector Strength: 65
• Industry: Industrial - Pollution & Treatment Controls
• EPS (TTM): N/A
• Shares Outstanding: 16,119,726
• 10 Day Avg. Volume: 178,605
• 30 Day Avg. Volume: 122,520
• PEG Ratio: 0.05
• Price to Book (P/B): 3.01
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 10.97
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 74 Outperform
• Price Target: C$2.50 ▲(12.11%Upside)

Biorem Inc's strong financial performance, solid corporate event achievements, and reasonable valuation are the main drivers for its score. Although technical analysis shows neutral momentum, the company's record financial results and strong order backlog provide a positive outlook.

Biorem Inc Business Overview & Revenue Model

Company Description

BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.

How the Company Makes Money

Biorem Inc generates revenue primarily through the sale and installation of its air emissions control systems. The company offers a range of products designed to address specific air quality issues, from small-scale solutions for localized odor control to large, complex systems for industrial applications. Revenue streams include direct sales of equipment, installation services, and ongoing maintenance and support contracts. Additionally, Biorem may engage in partnerships with engineering firms, municipalities, and industrial companies to deliver customized solutions, contributing to its earnings. The company also invests in research and development to innovate and improve its product offerings, ensuring continued demand and market competitiveness.

Biorem Inc Financial Statement Overview

Summary

Biorem Inc has shown remarkable financial improvement with a 48.67% revenue increase, 8.13% net profit margin, and strong cash flow metrics. The balance sheet reflects low leverage with a debt-to-equity ratio of 0.33 and a return on equity of 28.65%.

Income Statement

Biorem Inc has demonstrated strong revenue growth with a significant increase of 48.67% in 2024 compared to the previous year. The gross profit margin stands at 26.87%, reflecting efficient cost management. The net profit margin also improved to 8.13%, indicating enhanced profitability. Both EBIT and EBITDA margins show positive trends, at 11.61% and 12.87% respectively, highlighting operational efficiency.

Balance Sheet

The company's debt-to-equity ratio is 0.33, indicating a healthy leverage position. Return on equity has improved to 28.65%, showcasing effective utilization of shareholder funds. The equity ratio is 37.26%, which suggests a stable capital structure with a good portion of assets financed by shareholders' equity.

Cash Flow

Biorem Inc's free cash flow growth rate is robust, reflecting a turnaround from negative to positive free cash flow. The operating cash flow to net income ratio of 1.21 indicates strong cash generation relative to net income, while the free cash flow to net income ratio of 1.09 further confirms solid cash flow health.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	37.42M	25.17M	28.86M	24.48M	24.38M
Gross Profit	10.06M	7.02M	8.76M	6.24M	7.02M
EBITDA	4.82M	3.45M	2.99M	2.68M	3.07M
Net Income	3.04M	2.18M	1.61M	1.30M	2.09M
Balance Sheet
Total Assets	28.51M	24.08M	20.73M	19.17M	21.95M
Cash, Cash Equivalents and Short-Term Investments	5.21M	2.29M	3.78M	4.47M	8.87M
Total Debt	3.56M	4.19M	4.75M	5.67M	828.17K
Total Liabilities	17.89M	17.36M	16.21M	17.20M	8.43M
Stockholders Equity	10.63M	6.72M	4.52M	1.96M	13.52M
Cash Flow
Free Cash Flow	3.31M	-62.84K	1.24M	3.71M	2.99M
Operating Cash Flow	3.69M	490.03K	1.44M	3.78M	3.34M
Investing Cash Flow	-372.00K	-552.87K	-203.29K	-75.98K	-342.40K
Financing Cash Flow	-572.04K	-1.33M	-951.80K	-7.56M	-199.74K

Biorem Inc Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2.23
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:BRM, the sentiment is Positive. The current price of 2.23 is above the 20-day moving average (MA) of 2.14, above the 50-day MA of 2.02, and below the 200-day MA of 2.52, indicating a neutral trend. The MACD of 0.06 indicates Negative momentum. The RSI at 56.78 is Neutral, neither overbought nor oversold. The STOCH value of 52.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:BRM.

Biorem Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BRM	74 Outperform	C$35.95M	12.87	30.34%	―	29.80%	-11.58%
TMG	69 Neutral	C$24.24M	155.56	4.63%	―	14.78%	-90.82%
Sector *	63 Neutral	HK$30.48B	8.22	5.37%	5.29%	-3.09%	4.51%
GRN	60 Neutral	C$14.91M	―	-6.67%	―	-32.69%	94.36%
QST	50 Neutral	C$11.29M	―	-9.94%	―	1.06%	56.94%
WATR	47 Neutral	C$4.79M	―	-143.77%	―	-49.88%	-266.67%
SHRC	45 Neutral	C$16.29M	―	-539.37%	―	46.73%	6.56%

Biorem Inc Corporate Events

BIOREM Inc. Reports Record Order Backlog Amidst Revenue Decline

BIOREM Inc. reported its first-quarter financial results for 2025, highlighting a record order backlog of $68 million, despite a decrease in quarterly revenue to $4.7 million due to seasonal construction delays and logistical challenges. The company secured 23 new projects, including a significant $5.8 million project in the Middle East, and is focusing on organic growth initiatives and expanding its service offerings, such as on-demand odor control rental units. The company’s cash position improved to $9.6 million, and it invested in manufacturing equipment to increase production capacity, indicating a strategic focus on supporting international clients and enhancing its market position.

Biorem Inc. Achieves Record Financial Performance in 2024

Biorem Inc. reported record revenues and earnings for the fiscal year 2024, with a 49% increase in revenue to $37.4 million and a 36% rise in net earnings to $3.0 million compared to 2023. The company also achieved a record order backlog of $56.1 million, reflecting strong business development efforts and investments in manufacturing processes that enhanced production capacity and reduced costs. Despite challenges such as geopolitical and tariff pressures anticipated in 2025, Biorem remains confident in its ability to navigate these issues due to its diverse supply chain, American-based manufacturing, and robust financial position.